BOSTON BIOMEDICA INC
S-3, EX-23.1, 2000-09-22
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: BOSTON BIOMEDICA INC, S-3, EX-5.1, 2000-09-22
Next: SRFG INC, 424B2, 2000-09-22




<PAGE>

                               Document is copied

                                  EXHIBIT 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in this Registration
Statement to register 2,070,080 shares of common stock on Form S-3 of our
report dated February 29, 2000 relating to the consolidated financial
statements and financial statement schedule, which appears in Boston
Biomedica, Inc.'s Annual Report on Form 10-K for the year ended December 31,
1999. We also consent to the incorporation by reference of our report dated
July 10, 1998, except as to certain information in the second paragraph of
Note I, for which the date is September 30, 1998 relating to the financial
statements of BioSeq, Inc., which appears in such Annual Report on Form 10-K.
We also consent to the reference to us under the heading "Experts" in such
Registration Statement.

/s/ PriceWaterhouseCoopers LLP
Boston, Massachusetts
September 22, 2000


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission